Moffitt Cancer Center, Magnolia Campus
Welcome,         Profile    Billing    Logout  
 3 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zager, Jonathan
FOCUS, NCT02678572: Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma

Completed
3
102
Europe, US
Melphalan/HDS, Alkeran
Delcath Systems Inc., IQVIA Biotech
Melanoma, Ocular
05/23
08/23
NCT05022901: An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma

Active, not recruiting
3
30
US
Melphalan (3 mg/kg IBW) with Hepatic Delivery System (HDS), percutaneous hepatic perfusion, PHP, HEPZATO
Delcath Systems Inc.
Metastatic Ocular Melanoma, Metastatic Uveal Melanoma
03/24
03/24
Neo-DREAM, NCT03567889: Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients

Recruiting
3
186
Europe, US
Daromun, Surgery, Adjuvant therapy
Philogen S.p.A.
Melanoma Stage IIIB/C
06/24
06/26
MelMarT-II, NCT03860883: Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Recruiting
3
2998
Europe, Canada, US, RoW
Wide Local Excision = 1cm Margin, Wide Local Excision = 2cm Margin
Melanoma and Skin Cancer Trials Limited, Norfolk and Norwich University Hospitals NHS Foundation Trust, Canadian Cancer Trials Group, Cancer Trials Ireland, Zuyderland Medical Centre
Cutaneous Melanoma, Stage II
12/29
12/34
NCT04526730: Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients

Active, not recruiting
2
17
US
Tavo, Nivolumab, OncoSec Medical Electroporation Therapy System, Electroporation
H. Lee Moffitt Cancer Center and Research Institute, OncoSec Medical Incorporated
Melanoma
06/28
06/28
PV-10-MM-1201, NCT02557321: PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma

Active, not recruiting
1/2
50
US
PV-10, Rose Bengal Disodium, Pembrolizumab
Provectus Biopharmaceuticals, Inc.
Melanoma
05/23
04/25
NCT04975152: Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma

Recruiting
1
30
US
Cemiplimab-Rwlc, Libtayo
H. Lee Moffitt Cancer Center and Research Institute, Regeneron Pharmaceuticals, Sanofi-Synthelabo
Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma
07/24
07/26
NCT01728051: Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver

No Longer Available
N/A
US
Melphalan, Percutaneous Hepatic Perfusion
Delcath Systems Inc.
Metastatic Liver Cancer, Ocular Melanoma, Cutaneous Melanoma
 
 

Download Options